Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

NCT00513786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: bevacizumab

Sponsor

David O'Malley

Collaborators

[object Object]